DPCR and qPCR in the healthcare market were valued at US $ 3,255.5 million in 2017 and are expected to reach US $ 6,371.6 million by 2025; it is expected to grow at a CAGR of 9.1% from 2018 to 2025.

DPCR and qPCR are PCR technologies that have evolved over the years from thermostable polymerases, from the development of automated thermal cyclers to the latest digital PCR (d-PCR) methodologies. However, the basic principle of denature, anneal, extend remains the same. The qPCR gave birth to the second generation which allows analysis and diagnosis with reduced risk of contamination and is considered the “gold standard”. DPCR amplifies the target DNA molecule and directly quantifies it without an external calibrator. This has been widely used to study variations in gene sequences. With these many advantages, the market is expected to grow rapidly. The growth of dPCR and qPCR in the healthcare market is attributed to the increasing incidence of genetic diseases, increasing investment and funds for gene synthesis, technological advancements in PCR technologies are of key drivers of market growth.

Both dPCR and qPCR in the healthcare market are expected to experience substantial growth after the pandemic. COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans and business closures. The COVID-19 crisis has overloaded public health systems in many countries and highlighted the strong need for sustainable investments in health systems. As the COVID-19 pandemic progresses, the healthcare sector is expected to experience slower growth. The life sciences segment is thriving due to increased demand for in vitro diagnostic products and increased research and development activities around the world.

Main dPCR and qPCR market providers:
• F. Hoffmann-La Roche SA
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Qiagen N.V.
• Takara Bio, Inc.
• Agilent Technologies, Inc.
• Biomérieux S.A.
• Fluidigm Corporation
• Danaher Company
• ABBott Laboratories

DPCR and qPCR in the Healthcare Market – by Technology
• quantitative PCR (qPCR)
• digital PCR (dPCR)

DPCR and qPCR in the healthcare market – by product
• Reagents and consumables
• Instruments
• Software and services

DPCR and qPCR in Healthcare Market – By Application
• Search request
• A clinical application
• Medico-legal request

In this study, the years considered to estimate the market size of dPCR and qPCR are as follows:
Year of history: 2015-2020
Baseline year: 2020
Estimated year: 2021
Forecast year 2021 to 2028

Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also shows import / export consumption, supply and demand figures, costs, prices, revenues and gross margins. This report studies the dPCR and qPCR market status and outlook of the global and major regions, from the perspective of players, countries, product types and end industries; This report analyzes the major players in the global market and divides the market by product type and end applications / industries.

If you have any special requirements, please let us know and we will offer you the report you want.

About Us:
The Insight Partners is a one-stop-shop for actionable information in industrial research. We help our clients find solutions to their research needs through our syndicated research and advisory services. We are a technology, healthcare, manufacturing, automotive and defense specialist.

Ref: https://androidfun.fr